It is possible that GLP-1 RA may improve the signs and symptoms of HS in several ways: Losing weight Treating diabetes Reducing inflammation Limitations: This study was retrospective, meaning it looked back at existing patient data, and it did not include a control group
Wegovy has been authorised for use in the EU since 6 January 2022, so a licensed doctor can prescribe it when it is clinically appropriate for you
OConnor EA, Evans CV, Ivlev I, et al
These impacts should begin to end in 2026 as the new Big Beautiful Bill takes effect
Semaglutide, originally developed for type 2 diabetes, has emerged as a tool that tackles PCOS at its metabolic foundation by enhancing insulin sensitivity and supporting weight reduction
The mechanism here overlaps with the tendon application: BPC-157 improves local blood supply and growth factor signaling at the repair site, shortening the window between injury and return to full loading